3B BlackBio DX logo

3B BlackBio DX

3BBLACKBIO NSE

Key Fundamentals

MicrocapHealthcare Service ProviderHealthcare Services
Market Cap
₹1,202 Cr
Volatility
Moderate
P/E Ratio
21.95
EBITDA
₹56.78 Cr
Return on Equity
17.6%
Debt to Equity
0.01
Book Value
₹377.96
52W High
₹1,588.9
52W Low
₹1,085

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

3
  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company's median sales growth is 21.9% of last 10 years

Weaknesses

1
  • Earnings include an other income of Rs.27.4 Cr.

Growth Rate

Revenue Growth
27.17% lower than 3Y
Net Income Growth
27.51% lower than 3Y
Cash Flow Change
60.89% lower than 3Y
ROE
23.6% higher than 3Y
ROCE
19.97% lower than 3Y
EBITDA Margin (Avg.)
-41.99% lower than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
14.28
19.18
17.67
23
19.43
29.15
25.39
22.5
22.23
33.9
50.35
35.43
33.49
Expenses
7.84
11.39
8.8
13.12
8.48
12.98
10.32
14.58
10.4
19.17
28.63
26.94
24.97
Operating Profit
6.44
7.79
8.87
9.88
10.95
16.17
15.07
7.92
11.83
14.73
21.72
8.49
8.52
OPM %
45.1%
40.62%
50.2%
42.96%
56.36%
55.47%
59.35%
35.2%
53.22%
43.45%
43.14%
23.96%
25.44%
Other Income
2.96
2.75
2.63
4.19
3.69
3.44
3.01
4.94
4.32
5.51
5.59
10.15
6.14
Interest
0.02
0.04
0.03
0.04
0.01
0.03
0.02
0.04
0.01
0.04
0.09
0.1
0.1
Depreciation
0.19
0.24
0.32
0.3
0.27
0.27
0.27
0.28
0.28
0.58
0.38
3.89
1.34
PBT
9.19
10.26
11.15
13.73
14.36
19.31
17.79
12.54
15.86
19.62
26.84
14.65
13.22
Tax %
21.55%
26.02%
23.68%
35.98%
21.31%
22.99%
24.17%
35.89%
20.3%
23.34%
16.39%
33.11%
32.07%
Net Profit
7.21
7.58
8.51
8.79
11.3
14.87
13.49
8.04
12.65
15.04
22.44
9.81
8.98
EPS in Rs
9.71
10.46
10.16
10.33
12.97
17.07
15.61
9.79
14.67
17.14
25.32
11.14
11.1
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
19
17
16
23
23
29
227
81
62
74
96
142
153
Expenses
18
16
14
18
16
20
77
44
33
41
46
85
100
Operating Profit
1
2
3
5
7
9
150
37
29
33
50
57
53
OPM %
7%
9%
16%
23%
31%
32%
66%
46%
47%
44%
52%
40%
35%
Other Income
0
0
0
0
1
2
3
7
7
13
15
26
27
Interest
1
1
1
1
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
1
1
1
1
1
1
1
5
6
PBT
0
0
1
5
7
10
152
43
35
44
64
77
74
Tax %
23%
23%
19%
24%
25%
23%
25%
26%
27%
28%
25%
22%
—
Net Profit
0
0
1
3
5
8
114
32
26
32
48
60
56
EPS in Rs
0.36
0.51
1.76
5.35
8.18
10.24
152
42.89
34.55
37.4
55.57
68.27
64.7
Div. Payout %
0%
0%
17%
9%
6%
7%
6%
24%
8%
8%
7%
7%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
6
6
6
6
6
7
7
7
9
9
9
9
Reserves
4
4
5
12
16
25
125
146
185
214
260
316
Borrowings
8
8
9
6
6
4
2
3
2
1
0
3
Other Liabilities
7
6
6
6
8
9
59
37
19
24
27
51
Total Liabilities
25
24
26
30
36
45
194
192
214
248
296
378
Fixed Assets
4
3
3
4
4
4
5
7
8
7
7
28
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
1
59
93
92
117
156
158
Other Assets
21
21
22
26
32
40
130
93
114
123
132
193
Total Assets
25
24
26
30
36
45
194
192
214
248
296
378
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0
1
1
2
4
7
98
37
20
27
43
52
Investing
0
0
0
-1
-1
-1
-70
-28
15
-20
-33
-24
Financing
0
-1
0
0
-1
1
-2
-15
-5
-4
-3
-1
Net Cash Flow
0
0
0
1
2
7
26
-6
30
3
7
28
Free Cash Flow
0
1
0
1
3
6
96
35
18
26
42
27
CFO/OP
23
69
36
52
71
101
90
129
100
115
116
121
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
262
283
321
259
290
252
56
136
200
179
138
129
Inventory Days
145
143
175
—
—
—
—
—
164
141
124
187
Days Payable
218
203
186
—
—
—
—
—
69
66
28
70
Cash Conversion Cycle
188
223
310
259
290
252
56
136
296
253
235
245
Working Capital Days
175
205
247
253
287
275
65
162
241
215
169
143
ROCE %
7%
7%
13%
24%
28%
31%
162%
27%
19%
21%
26%
25%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view 3B BlackBio DX insights

36 extracted metrics + investor summaries across FY13–FY26.

Log in — free

Shareholding Pattern

DIIs2.15%Promot.40.95%FIIs2.50%Others17.35%Public37.05%As ofJun 2026

Documents

Frequently Asked Questions about 3B BlackBio DX

What does 3B Blackbio DX Ltd do?
Incorporated in 2011, 3B BlackBio Dx Ltd manufactures and exports PCR based Molecular Diagnostic kits, PCR Enzymes & PCR Reagents, and agrochemical-based products[1]
Where is 3B Blackbio DX Ltd (532067) listed?
3B Blackbio DX Ltd trades as 3BBLACKBIO on the NSE and under code 532067 on the BSE.
Which sector does 3B Blackbio DX Ltd belong to?
3B Blackbio DX Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the market capitalisation of 3B Blackbio DX Ltd?
3B Blackbio DX Ltd has a market capitalisation of ₹1,202 Cr, which places it in the Small Cap band.
What is the PE ratio of 3B Blackbio DX Ltd?
3B Blackbio DX Ltd trades at a PE ratio of 21.95, against a book value of ₹377.96 per share.
What is the 52-week high and low of 3B Blackbio DX Ltd?
Over the last 52 weeks 3B Blackbio DX Ltd has traded between ₹1,085 and ₹1,588.9.
Does 3B Blackbio DX Ltd pay dividends?
3B Blackbio DX Ltd has a dividend yield of 0.35%.
What is the Return on Equity (ROE) of 3B Blackbio DX Ltd?
3B Blackbio DX Ltd reported a return on equity of 17.60%. Its debt-to-equity ratio is 0.01.

Company Information

Incorporated in 2011, 3B BlackBio Dx Ltd manufactures and exports PCR based Molecular Diagnostic kits, PCR Enzymes & PCR Reagents, and agrochemical-based products[1]

Website kilpest.com
Listed 2026-04-20
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/532067.md for 3B Blackbio DX Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare Services → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List